|
1
|
Ando K, Heymann MF, Stresing V, Mori K,
Redini F and Heymann D: Current therapeutic strategies and novel
approaches in osteosarcoma. Cancers (Basel). 5:591–616. 2013.
View Article : Google Scholar
|
|
2
|
Yu W, Wang Y, Zhu J, Jin L, Liu B, Xia K,
Wang J, Gao J, Liang C and Tao H: Autophagy inhibitor enhance
ZnPc/BSA nanoparticle induced photodynamic therapy by suppressing
PD-L1 expression in osteosarcoma immunotherapy. Biomaterials.
192:128–39. 2019. View Article : Google Scholar
|
|
3
|
Arai K, Sakamoto R, Kubota D and Kondo T:
Proteomic approach toward molecular backgrounds of drug resistance
of osteosarcoma cells in spheroid culture system. Proteomics.
13:2351–2360. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cao D, Zhu W, Kuang Y and Zhao S: A safe
and effective treatment: Surgery combined with photodynamic therapy
for multiple basal cell carcinomas. Photodiagnosis Photodyn Ther.
28:133–135. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang X, Ramamurthy G, Shirke AA, Walker E,
Mangadlao J, Wang Z, Wang Y, Shan L, Schluchter MD, Dong Z, et al:
Photodynamic therapy is an effective adjuvant therapy for
image-guided surgery in prostate cancer. Cancer Res. 80:156–162.
2020.
|
|
6
|
Wu ZJ, Tan JC, Qin X, Liu B and Yuan ZC:
Significance of circulating tumor cells in osteosarcoma patients
treated by neoadjuvant chemotherapy and surgery. Cancer Manag Res.
10:3333–3339. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nishie H, Kataoka H, Yano S, Yamaguchi H,
Nomoto A, Tanaka M, Kato A, Shimura T, Mizoshita T, Kubota E, et
al: Excellent antitumor effects for gastrointestinal cancers using
photodynamic therapy with a novel glucose conjugated chlorin e6.
Biochem Biophys Res Commun. 496:1204–1209. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Savoia P, Deboli T, Previgliano A and
Broganelli P: Usefulness of photodynamic therapy as a possible
therapeutic alternative in the treatment of basal cell carcinoma.
Int J Mol Sci. 16:23300–23317. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Phuong PTT, Lee S, Lee C, Seo B, Park S,
Oh KT, Lee ES, Choi HG, Shin BS and Youn YS: Beta-carotene-bound
albumin nanoparticles modified with chlorin e6 for breast tumor
ablation based on photodynamic therapy. Colloids Surf B
Biointerfaces. 171:123–133. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fujishiro T, Nonoguchi N, Pavliukov M,
Ohmura N, Kawabata S, Park Y, Kajimoto Y, Ishikawa T, Nakano I and
Kuroiwa T: 5-Aminolevulinic acid-mediated photodynamic therapy can
target human glioma stem-like cells refractory to antineoplastic
agents. Photodiagnosis Photodyn Ther. 24:55–68. 2018. View Article : Google Scholar
|
|
11
|
Kessel D and Oleinick NL: Cell death
pathways associated with photodynamic therapy: An update. Photochem
Photobiol. 94:213–218. 2018. View Article : Google Scholar
|
|
12
|
Zhang Q and Li L: Photodynamic
combinational therapy in cancer treatment. J BUON. 23:561–567.
2018.PubMed/NCBI
|
|
13
|
Huang Q, Ou YS, Tao Y, Yin H and Tu PH:
Apoptosis and autophagy induced by pyropheophorbide-α methyl
ester-mediated photodynamic therapy in human osteosarcoma MG-63
cells. Apoptosis. 21:749–760. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chang JE, Yoon IS, Sun PL, Yi E, Jheon S
and Shim CK: Anticancer efficacy of photodynamic therapy with
hematoporphyrin-modified, doxorubicin-loaded nanoparticles in liver
cancer. J Photochem Photobiol B. 140:49–56. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Silva AP, Kurachi C, Bagnato VS and Inada
NM: Fast elimination of onychomycosis by hematoporphyrin
derivative-photodynamic therapy. Photodiagnosis Photodyn Ther.
10:328–330. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zeng H, Sun M, Zhou C, Yin F, Wang Z, Hua
Y and Cai Z: Hematoporphyrin monomethyl ether-mediated photodynamic
therapy selectively kills sarcomas by inducing apoptosis. PLoS One.
8:e777272013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tao Y, Ou Y, Yin H, Chen Y, Zhong S, Gao
Y, Zhao Z, He B, Huang Q and Deng Q: Establishment and
characterization of human osteosarcoma cells resistant to
pyropheophorbide-α methyl ester-mediated photodynamic therapy. Int
J Oncol. 51:1427–1438. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Qian G, Wang L, Zheng X and Yu T:
Deactivation of cisplatin-resistant human lung/ovary cancer cells
with pyropheophorbide-α methyl ester-photodynamic therapy. Cancer
Biol Ther. 18:984–989. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tu PH, Huang WJ, Wu ZL, Peng QZ, Xie ZB,
Bao J and Zhong MH: Induction of cell death by pyropheophorbide-α
methyl ester-mediated photodynamic therapy in lung cancer A549
cells. Cancer Med. 6:631–639. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu J, Tian S, Li KT, Chen Q, Jiang Y, Lin
HD, Yu LH and Bai DQ: Inhibition of breast cancer cell growth by
methyl pyropheophenylchlorin photodynamic therapy is mediated
though endoplasmic reticulum stress-induced autophagy in vitro and
vivo. Cancer Med. 7:1908–1920. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tu PH, Huang WJ, Wu ZL, Peng QZ, Xie ZB,
Bao J and Zhong MH: Induction of cell death by pyropheophorbide-α
methyl ester-mediated photodynamic therapy in lung cancer A549
cells. Cancer Med. 6:631–639. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tian Y, Leung W, Yue K and Mak N: Cell
death induced by MPPa-PDT in prostate carcinoma in vitro and in
vivo. Biochem Biophys Res Commun. 348:413–420. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
de Miguel GC, Abrantes AM, Laranjo M,
Grizotto AYK, Camporeze B, Pereira JA, Brites G, Serra A, Pineiro
M, Rocha-Gonsalves A, et al: A new therapeutic proposal for
inoperable osteosarcoma: Photodynamic therapy. Photodiagnosis
Photodyn Ther. 21:79–85. 2018. View Article : Google Scholar
|
|
24
|
Gao W, Wu XL, Li DZ and Liu HD: HOTTIP
participates in mammary cancer by promoting cell proliferation via
PI3K/AKT pathway. Eur Rev Med Pharmacol Sci. 22:4181–4187.
2018.PubMed/NCBI
|
|
25
|
Liu HW, Bi WT, Huang HT, Li RX, Xi Q, Feng
L, Bo W, Hu M and Wen WS: Satb1 promotes Schwann cell viability and
migration via activation of PI3K/AKT pathway. Eur Rev Med Pharmacol
Sci. 22:4268–4277. 2018.PubMed/NCBI
|
|
26
|
Wang J, Sun P, Chen Y, Yao H and Wang S:
Novel 2-pheny-loxypyrimidine derivative induces apoptosis and
autophagy via inhibiting PI3K pathway and activating MAPK/ERK
signaling in hepatocellular carcinoma cells. Sci Rep. 8:109232018.
View Article : Google Scholar
|
|
27
|
Lijun J, Shan H, Xiaoran Y, Zan Y, Guo Y
and Han L: Quercetin suppresses the mobility of breast cancer by
suppressing glycolysis through Akt-mTOR pathway mediated autophagy
induction. Life Sci. 208:123–130. 2018. View Article : Google Scholar
|
|
28
|
Meier D, Botter SM, Campanile C, Robl B,
Gräfe S, Pellegrini G, Born W and Fuchs B: Foscan and foslip based
photodynamic therapy in osteosarcoma, in vitro, and in intratibial
mouse models. Int J Cancer. 140:1680–1692. 2017. View Article : Google Scholar
|
|
29
|
Zhang F, Zhu Y, Fan G and Hu S:
Photodynamic therapy reduces the inhibitory effect of osteosarcoma
cells on dendritic cells by upregulating HSP70. Oncol Lett.
16:5034–5040. 2018.PubMed/NCBI
|
|
30
|
Huang L, Lin H, Chen Q, Yu L and Bai D:
MPPa-PDT suppresses breast tumor migration/invasion by inhibiting
Akt-NF-κB-dependent MMP-9 expression via ROS. BMC Cancer.
19:11592019. View Article : Google Scholar
|
|
31
|
Li W, Tan G, Cheng J, Zhao L, Wang Z and
Jin Y: A novel photosensitizer 3¹,13¹-phenylhydrazine-Mppa (BPHM)
and Its in vitro photodynamic therapy against HeLa cells.
Molecules. 21:pii: E558. 2016.
|
|
32
|
Santti K, Ihalainen H, Rönty M, Böhling T,
Karlsson C and Haglund C: High cyclin A expression, but not Ki67,
is associated with early recurrence in desmoid tumors. J Surg
Oncol. 118:192–198. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lal N, Nemaysh V and Luthra PM: Proteasome
mediated degradation of CDC25C and Cyclin B1 in Demethoxycurcumin
treated human glioma U87 MG cells to trigger G2/M cell cycle
arrest. Toxicol Appl Pharmacol. 356:76–89. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Marampon F, Gravina G, Ju X, Vetuschi A,
Sferra R, Casimiro M, Pompili S, Festuccia C, Colapietro A, Gaudio
E, et al: Cyclin D1 silencing suppresses tumorigenicity, impairs
DNA double strand break repair and thus radiosensitizes
androgen-independent prostate cancer cells to DNA damage.
Oncotarget. 7:5383–5400. 2016.
|
|
35
|
Cai H, Miao M and Wang Z: miR-214-3p
promotes the proliferation, migration and invasion of osteosarcoma
cells by targeting CADM1. Oncol Lett. 16:2620–2628. 2018.PubMed/NCBI
|
|
36
|
Qiu J, Zhang Y, Chen H and Guo Z:
MicroRNA-488 inhibits proliferation, invasion and EMT in
osteosarcoma cell lines by targeting aquaporin 3. Int J Oncol.
53:1493–1504. 2018.PubMed/NCBI
|
|
37
|
Campbell K and Casanova J: A role for
E-cadherin in ensuring cohesive migration of a heterogeneous
population of non-epithelial cells. Nat Commun. 6:79982015.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Shan Z, Wei Z and Shaikh ZA: Suppression
of ferroportin expression by cadmium stimulates proliferation, EMT,
and migration in triple-negative breast cancer cells. Toxicol Appl
Pharmacol. 356:36–43. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhang LZ, Mei J, Qian ZK, Cai XS, Jiang Y
and Huang WD: The role of VE-cadherin in osteosarcoma cells. Pathol
Oncol Res. 16:111–117. 2010. View Article : Google Scholar
|
|
40
|
Li F, Zhang J, Guo J, Jia Y, Han Y and
Wang Z: RNA interference targeting CD147 inhibits metastasis and
invasion of human breast cancer MCF-7 cells by downregulating
MMP-9/VEGF expression. Acta Biochim Biophys Sin (Shanghai).
50:676–684. 2018. View Article : Google Scholar
|
|
41
|
Liao CL, Chu YL, Lin HY, Chen CY, Hsu MJ,
Liu KC, Lai KC, Huang AC and Chung JG: Bisdemethoxycurcumin
suppresses migration and invasion of human cervical cancer HeLa
cells via inhibition of NF-ĸB, MMP-2 and -9 pathways. Anticancer
Res. 38:3989–3997. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Xu M, Jiang H, Wang H, Liu J, Liu B and
Guo Z: SB225002 inhibits prostate cancer invasion and attenuates
the expression of BSP, OPN and MMP-2. Oncol Rep. 40:726–736.
2018.PubMed/NCBI
|
|
43
|
Shimoda M, Jackson HW and Khokha R: Tumor
suppression by stromal TIMPs. Mol Cell Oncol. 3:e9750822016.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Guo Y, Chen YH, Cheng ZH, Ou-Yang HN, Luo
C and Guo ZL: Tectorigenin inhibits osteosarcoma cell migration
through downregulation of matrix metalloproteinases in vitro.
Anticancer Drugs. 27:540–546. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Liu JZ, Hu YL, Feng Y, Guo YB, Liu YF,
Yang JL, Mao QS and Xue WJ: Rafoxanide promotes apoptosis and
autophagy of gastric cancer cells by suppressing PI3K/Akt/mTOR
pathway. Exp Cell Res. 385:1116912019. View Article : Google Scholar
|
|
46
|
Zhou M, Shen S, Zhao X and Gong X:
Luteoloside induces G0/G1 arrest and pro-death autophagy through
the ROS-mediated AKT/mTOR/p70S6K signalling pathway in human
non-small cell lung cancer cell lines. Biochem Biophys Res Commun.
494:263–269. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhu Y, Rao Q, Zhang X and Zhou X: Galangin
induced antitumor effects in human kidney tumor cells mediated via
mitochondrial mediated apoptosis, inhibition of cell migration and
invasion and targeting PI3K/AKT/mTOR signalling pathway. J BUON.
23:795–799. 2018.PubMed/NCBI
|
|
48
|
Santamaria PG, Mazón MJ, Eraso P and
Portillo F: UPR: An upstream signal to EMT induction in cancer. J
Clin Med. 8:pii: E624. 2019. View Article : Google Scholar
|
|
49
|
Santofimia-Castaño P, Izquierdo-Alvarez A,
Plaza-Davila M, Martinez-Ruiz A, Fernandez-Bermejo M,
Mateos-Rodriguez JM, Salido GM and Gonzalez A: Ebselen impairs
cellular oxidative state and induces endoplasmic reticulum stress
and activation of crucial mitogen-activated protein kinases in
pancreatic tumour AR42J cells. J Cell Biochem. 119:1122–1133. 2018.
View Article : Google Scholar
|
|
50
|
Hetz C and Saxena S: ER stress and the
unfolded protein response in neurodegeneration. Nat Rev Neurol.
13:477–491. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Badiola N, Penas C, Miñano-Molina A,
Barneda-Zahonero B, Fadó R, Sánchez-Opazo G, Comella JX, Sabriá J,
Zhu C, Blomgren K, et al: Induction of ER stress in response to
oxygen-glucose deprivation of cortical cultures involves the
activation of the PERK and IRE-1 pathways and of caspase-12. Cell
Death Dis. 2:e1492011. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Guha P, Kaptan E, Gade P, Kalvakolanu DV
and Ahmed H: Tunicamycin induced endoplasmic reticulum stress
promotes apoptosis of prostate cancer cells by activating mTORC1.
Oncotarget. 8:68191–68207. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Sidhu A, Miller JR, Tripathi A, Garshott
DM, Brownell AL, Chiego DJ, Arevang C, Zeng Q, Jackson LC, Bechler
SA, et al: Borrelidin induces the unfolded protein response in oral
cancer cells and chop-dependent apoptosis. ACS Med Chem Lett.
6:1122–1127. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Zhou J, Tan SH, Nicolas V, Bauvy C, Yang
ND, Zhang J, Xue Y, Codogno P and Shen HM: Activation of lysosomal
function in the course of autophagy via mTORC1 suppression and
autophagosome-lysosome fusion. Cell Res. 23:508–523. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Tao YF, Li ZH, Du WW Xu LX, Ren JL, Li XL,
Fang F, Xie Y, Li M, Qian GH, et al: Inhibiting PLK1 induces
autophagy of acute myeloid leukemia cells via mammalian target of
rapamycin pathway dephosphorylation. Oncol Rep. 37:1419–1429. 2017.
View Article : Google Scholar : PubMed/NCBI
|
